OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.
By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.
GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Low reported | 1.4 mg | 1× daily (≈1 mg GHK-Cu) | 0.12 mL | 12 u | 50 doses | |
| Standard | 2.8 mg | 1× daily (≈2 mg GHK-Cu) | 0.24 mL | 24 u | 25 doses | |
| Upper reported | 4.2 mg | 1× daily (≈3 mg GHK-Cu) | 0.36 mL | 36 u | 16 doses |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial | |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 1.4 mg | daily | 0.12 mL | 12 u | 14 | 19.6 mg |
| Weeks 3–4 | 2.8 mg | daily | 0.24 mL | 24 u | 14 | 39.2 mg |
| Week 5 onward per 4 weeks from here on |
4.2 mg | daily | 0.36 mL | 36 u | 28 | 117.6 mg |
A fixed-ratio combination vial. Because the components are pooled at a fixed ratio, you cannot titrate one without moving the others — the practical consequence is that dosing is driven by whichever component has the narrowest window. A 70 mg vial is roughly 71% GHK-Cu by mass.
Buy GLOW Blendthis peptideOpens optimal-pep.com in a new tab
Browse the full catalogue, or jump to a neighbouring compound.
A nonapeptide hormone. Long established as a clinical drug. The social-cognition research literature is large but has significant …
The GLOW combination with KPV added. Same fixed-ratio constraint applies, with a fourth component narrowing the titration window f…
Every compound compared in one table: dose range, how often, half-life and evidence tier.